|
FR2496666A1
(fr)
|
1980-12-22 |
1982-06-25 |
Ici Pharma |
Nouveaux derives de cephalosporine et composition pharmaceutique les contenant
|
|
US5851741A
(en)
|
1986-01-24 |
1998-12-22 |
Fuji Photo Film Co., Ltd. |
Method for the formation of color images
|
|
US5658889A
(en)
|
1989-01-24 |
1997-08-19 |
Gensia Pharmaceuticals, Inc. |
Method and compounds for aica riboside delivery and for lowering blood glucose
|
|
US5726302A
(en)
|
1989-09-15 |
1998-03-10 |
Gensia Inc. |
Water soluble adenosine kinase inhibitors
|
|
US5795977A
(en)
|
1989-09-15 |
1998-08-18 |
Metabasis Therapeutics, Inc. |
Water soluble adenosine kinase inhibitors
|
|
US5646128A
(en)
|
1989-09-15 |
1997-07-08 |
Gensia, Inc. |
Methods for treating adenosine kinase related conditions
|
|
US6251911B1
(en)
|
1996-10-02 |
2001-06-26 |
Novartis Ag |
Pyrimidine derivatives and processes for the preparation thereof
|
|
DE10028575A1
(de)
|
2000-06-14 |
2002-03-14 |
Basf Ag |
Integrinliganden
|
|
AU4890301A
(en)
|
2000-04-17 |
2001-10-30 |
Dong Wha Pharmaceutical Industrial Co., Ltd. |
6-methylnicotinamide derivatives as antiviral agents
|
|
EP1314733A1
(en)
|
2001-11-22 |
2003-05-28 |
Aventis Pharma Deutschland GmbH |
Indole-2-carboxamides as factor Xa inhibitors
|
|
US20040185429A1
(en)
|
2002-12-09 |
2004-09-23 |
Judith Kelleher-Andersson |
Method for discovering neurogenic agents
|
|
SE0400284D0
(sv)
|
2004-02-10 |
2004-02-10 |
Astrazeneca Ab |
Novel compounds
|
|
GB0423554D0
(en)
|
2004-10-22 |
2004-11-24 |
Cancer Rec Tech Ltd |
Therapeutic compounds
|
|
JP2006241089A
(ja)
|
2005-03-04 |
2006-09-14 |
Astellas Pharma Inc |
ピロロピリミジン誘導体またはその塩
|
|
WO2007058482A1
(en)
|
2005-11-16 |
2007-05-24 |
Lg Life Sciences, Ltd. |
Novel inhibitors of protein kinase
|
|
TW200808325A
(en)
|
2006-07-06 |
2008-02-16 |
Astrazeneca Ab |
Novel compounds
|
|
WO2008073929A1
(en)
|
2006-12-11 |
2008-06-19 |
Wyeth |
Ion channel modulators
|
|
JP2010514693A
(ja)
|
2006-12-22 |
2010-05-06 |
ノバルティス アーゲー |
Ｐｄｋ１阻害のためのキナゾリン
|
|
JP5219583B2
(ja)
|
2008-03-31 |
2013-06-26 |
住友化学株式会社 |
組成物、光学フィルムとその製造方法、光学部材及び表示装置
|
|
JP5219594B2
(ja)
|
2008-04-08 |
2013-06-26 |
住友化学株式会社 |
組成物、光学フィルム及びフラットパネル表示装置
|
|
US20100121052A1
(en)
|
2008-06-20 |
2010-05-13 |
Rama Jain |
Novel compounds for treating proliferative diseases
|
|
UY31984A
(es)
|
2008-07-16 |
2010-02-26 |
Boehringer Ingelheim Int |
DERIVADOS DE 1-(3,4-difluorobencil)-6-oxo-1,6-dihidropirimidin-5-carboxamidas N-sustituidas y de 2-(3,4-difluorobencil)-3-oxo-2,3-dihidro-1H-pirazol-4-carboxamidas N-sustituidas.
|
|
JP5443720B2
(ja)
|
2008-09-05 |
2014-03-19 |
住友化学株式会社 |
組成物、光学フィルム及びその製造方法、光学部材ならびに表示装置
|
|
SI2396307T1
(sl)
|
2009-02-11 |
2015-02-27 |
Merck Patent Gmbh |
Novi amino azaheterockliäśni karboksamidi
|
|
UY32470A
(es)
|
2009-03-05 |
2010-10-29 |
Boehringer Ingelheim Int |
Derivados de 2-{2-cloro-5-[(sustituido) metil]fenilamino} -1-metil]fenilamino}-1-metilbencimidazol-5-carboxamidas-n-(sustituidas) y sus sales fisiológicamente aceptables, composiciones conteniéndolos y aplicaciones
|
|
WO2010147898A2
(en)
|
2009-06-15 |
2010-12-23 |
Rigel Pharmaceuticals, Inc. |
Small molecule inhibitors of spleen tyrosine kinase (syk)
|
|
US8822700B2
(en)
|
2009-09-11 |
2014-09-02 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8759332B2
(en)
|
2009-09-11 |
2014-06-24 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8703938B2
(en)
|
2009-09-11 |
2014-04-22 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8815928B2
(en)
|
2009-09-11 |
2014-08-26 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8927709B2
(en)
|
2009-09-11 |
2015-01-06 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US9556426B2
(en)
|
2009-09-16 |
2017-01-31 |
Celgene Avilomics Research, Inc. |
Protein kinase conjugates and inhibitors
|
|
US8586604B2
(en)
|
2010-08-20 |
2013-11-19 |
Boehringer Ingelheim International Gmbh |
Inhibitors of the microsomal prostaglandin E2 synthase-1
|
|
US8759537B2
(en)
|
2010-08-20 |
2014-06-24 |
Boehringer Ingelheim International Gmbh |
3H-imidazo [4, 5-C] pyridine-6-carboxamides as anti-inflammatory agents
|
|
RU2632900C2
(ru)
|
2010-11-19 |
2017-10-11 |
Лиганд Фармасьютикалс Инкорпорейтед |
Гетероциклические амины и их применение
|
|
WO2012075232A1
(en)
|
2010-12-04 |
2012-06-07 |
Trevena, Inc. |
Opioid receptor ligands and methods of using and making the same
|
|
UY33779A
(es)
|
2010-12-10 |
2012-07-31 |
Boehringer Ingelheim Int |
?2-(fenilamino)-1H-bencimidazol-5-carboxamidas novedosas?
|
|
US8466186B2
(en)
|
2010-12-10 |
2013-06-18 |
Boehringer Ingelheim International Gmbh |
Compounds
|
|
WO2013038308A1
(en)
|
2011-09-15 |
2013-03-21 |
Glenmark Pharmaceuticals S.A. |
SUBSTITUTED BICYCLIC HETEROARYL COMPOUNDS AS mPGES-1 INHIBITORS
|
|
HRP20180037T1
(hr)
|
2012-04-17 |
2018-03-23 |
Fujifilm Corporation |
Heterociklični spoj koji sadrži dušik ili njegovu sol
|
|
TWI568722B
(zh)
|
2012-06-15 |
2017-02-01 |
葛蘭馬克製藥公司 |
作爲ｍＰＧＥＳ－１抑制劑之三唑酮化合物
|
|
CA2895426A1
(en)
|
2012-12-20 |
2014-06-26 |
Bayer Pharma Aktiengesellschaft |
Bet-protein-inhibiting dihydroquinoxalinones
|
|
WO2014146246A1
(en)
|
2013-03-19 |
2014-09-25 |
Merck Sharp & Dohme Corp. |
Cycloalkyl nitrile pyrazolo pyridones as janus kinase inhibitors
|
|
EP3195866B1
(en)
|
2014-08-22 |
2020-11-18 |
FUJIFILM Corporation |
Pharmaceutical composition for treating flt3 mutation-positive cancer, mutant flt3 inhibitor and uses thereof
|
|
WO2016172631A2
(en)
|
2015-04-24 |
2016-10-27 |
President And Fellows Of Harvard College |
Substrate selective inhibitors of insulin-degrading enzyme (ide) and uses thereof
|
|
EP3307726B1
(en)
|
2015-06-11 |
2020-05-20 |
International Society for Drug Development S.r.l. |
2-oxo-1,2-dihydropyridine-3-carboxamide compounds and their use as inhibitors of pdk1
|
|
EP3350158A4
(en)
|
2015-09-16 |
2019-05-08 |
Metacrine, Inc. |
Farnesoid x receptor agonists and uses thereof
|
|
US20180273573A1
(en)
|
2015-10-01 |
2018-09-27 |
Memorial Sloan-Kettering Cancer Center |
Inhibitors of menaquinone biosynthesis
|
|
SI3371171T1
(sl)
|
2015-11-02 |
2024-03-29 |
Blueprint Medicines Corporation |
Inhibitorji ret
|
|
GB201603311D0
(en)
|
2016-02-25 |
2016-04-13 |
Jakobsson Per Johan |
New uses and methods
|
|
WO2017201585A1
(en)
|
2016-05-26 |
2017-11-30 |
Genea Ip Holdings Pty Ltd |
Modulators of dux4 for regulation of muscle function
|
|
PE20190656A1
(es)
|
2016-07-29 |
2019-05-08 |
Lupin Ltd |
Compuestos de tiazolo-piridina sustituida como inhibidores de malt1
|
|
US11135207B2
(en)
|
2016-12-13 |
2021-10-05 |
Centaurus Therapeutics |
Inhibitors of dihydroceramide desaturase for treating disease
|
|
CA3047404A1
(en)
|
2016-12-23 |
2018-06-28 |
Aquinnah Pharmaceuticals, Inc. |
Compounds, compositions and methods of use
|
|
GB201707938D0
(en)
|
2017-05-17 |
2017-06-28 |
Univ Sheffield |
Compounds
|
|
WO2018226150A1
(en)
*
|
2017-06-05 |
2018-12-13 |
Medivir Aktiebolag |
Pyrazolopyrimidine as malt-1 inhibitors
|
|
AU2018286247B2
(en)
|
2017-06-14 |
2021-12-23 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
Syk inhibitor and use method therefor
|
|
CN110709402B
(zh)
|
2017-06-15 |
2022-05-10 |
浙江海正药业股份有限公司 |
杂芳基并嘧啶酮类衍生物、其制备方法及其在医药上用途
|
|
EP3707138B1
(en)
|
2017-11-06 |
2022-07-13 |
Bristol-Myers Squibb Company |
Isofuranone compounds useful as hpk1 inhibitors
|
|
US10844044B2
(en)
|
2018-06-14 |
2020-11-24 |
Vanderbilt University |
WDR5 inhibitors and modulators
|
|
WO2020031107A1
(en)
|
2018-08-08 |
2020-02-13 |
Glaxosmithkline Intellectual Property Development Limited |
Chemical compounds
|
|
US12187686B2
(en)
|
2018-09-07 |
2025-01-07 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
BRD4-JAK2 inhibitors
|
|
EP3898630B1
(en)
|
2018-12-17 |
2023-05-10 |
F. Hoffmann-La Roche AG |
Novel imidazopyrazine derivatives
|
|
CN112409331B
(zh)
|
2019-08-21 |
2024-02-20 |
上海翰森生物医药科技有限公司 |
杂环类衍生物抑制剂、其制备方法和应用
|
|
CA3157026A1
(en)
|
2019-10-07 |
2021-04-15 |
D.E. Shaw Research, Llc |
Arylmethylene aromatic compounds as kv1.3 potassium shaker channel blockers
|
|
GB201914910D0
(en)
|
2019-10-15 |
2019-11-27 |
Sentinel Oncology Ltd |
Pharmaceutical compounds
|
|
IL296025A
(en)
|
2020-03-02 |
2022-10-01 |
Sironax Ltd |
Proptosis inhibitors - diarylamine para-acetamides
|
|
CN113527291B
(zh)
|
2020-04-13 |
2025-07-22 |
广东东阳光药业股份有限公司 |
Ret抑制剂、其药物组合物及其用途
|
|
CA3191279A1
(en)
|
2020-08-28 |
2022-03-03 |
Yi Liu |
Heterocyclic compounds and uses thereof
|
|
CN116437913A
(zh)
|
2020-09-23 |
2023-07-14 |
艾其林医药公司 |
用于治疗补体介导的病症的药物化合物
|
|
JP7818011B2
(ja)
|
2020-10-16 |
2026-02-19 |
レラファイド バイオサイエンシーズ， インコーポレイテッド |
Ｍａｌｔ１モジュレーターおよびその使用
|
|
WO2022081995A1
(en)
|
2020-10-16 |
2022-04-21 |
Rheos Medicines, Inc. |
Malt1 modulators and uses thereof
|
|
IL302440A
(en)
|
2020-10-30 |
2023-06-01 |
Calico Life Sciences Llc |
Combined pressure pathway modulators
|
|
GB202018412D0
(en)
|
2020-11-23 |
2021-01-06 |
Exscientia Ltd |
Malt-1 modulators ii
|
|
TW202345806A
(zh)
|
2022-03-31 |
2023-12-01 |
美商艾伯維有限公司 |
噻唑并〔５，４－ｂ〕吡啶ｍａｌｔ－１抑制劑
|